Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Journal of Genetic Counseling

21-08-2018 | Original Research

Practice Variation among an International Group of Genetic Counselors on when to Offer Predictive Genetic Testing to Children at Risk of an Inherited Arrhythmia or Cardiomyopathy

Authors: S. Christian, M. Somerville, C. Huculak, J. Atallah

Published in: Journal of Genetic Counseling

Login to get access

Abstract

Cascade predictive genetic testing is available for many families as a means to identify individuals at risk of long QT syndrome (LQTS), catecholaminergic polymorphic ventricular tachycardia (CPVT), hypertrophic cardiomyopathy (HCM), and arrhythmogenic right ventricular cardiomyopathy (ARVC). The general issue of offering predictive genetic testing to minors has been an area of ethical debate among genetic counselors and other healthcare professionals for many years. An online questionnaire was circulated to four international genetic counseling associations to assess the views of cardiac genetic counselors regarding when to offer predictive genetic testing to children at risk of LQTS, CPVT, HCM, and ARVC. Analysis was both quantitative and qualitative. The study sample comprised 98 respondents. The majority reported that they offer predictive genetic testing before 5 years of age to children at risk of LQTS (83%) and CVPT (75%) and before 10 years of age to children at risk of HCM (66%) or ARVC (70%). Influencing factors included country of practice, clinical setting, and years of experience. The rationale provided for when to offer predictive genetic testing is encompassed by the ethical principles of beneficence, non-maleficence, autonomy, and informed consent. In conclusion, significant practice variation exists among cardiac genetic counselors regarding predictive genetic testing for children at risk of an inherited cardiomyopathy. These variations call for more research in the area to assist with the development of evidence-based guidelines.
Appendix
Available only for authorised users
Literature
Ackerman, M. J., Priori, S. G., Willems, S., Berul, C., Brugada, R., Calkins, H., et al. (2011). HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm, 8(8), 1308–1339.CrossRefPubMed
Ackerman, M. J., Zipes, D. P., Kovacs, R. J., & Maron, B. J. (2015). Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 10: the cardiac channelopathies: a scientific statement from the American heart association and American college of cardiology. Journal of the American College of Cardiology, 66(21), 2424–2428.CrossRefPubMed
Alderfer, M. A., Lindell, R. B., Viadro, C. I., Zelley, K., Valdez, J., Mandrell, B., et al. (2017). Should genetic testing be offered for children? The perspectives of adolescents and emerging adults in families with li-Fraumeni syndrome. Journal of Genetic Counseling, 26(5), 1106–1115.CrossRefPubMed
American College of Cardiology Foundation (ACCF)/American Heart Association (AHA) Task Force on Practice Guidelines, American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, et al. (2011). 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. The Journal of Thoracic and Cardiovascular Surgery, 142(6), 1303–1338.CrossRef
American Society of Clinical Oncology (ASCO). (2003). American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. Journal of Clinical Oncology, 21(12), 2397–2406.CrossRef
Borry, P., Stultiens, L., Nys, H., Cassiman, J. J., & Dierickx, K. (2006). Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers. Clinical Genetics, 70(5), 374–381.CrossRefPubMed
Botkin, J. R., Belmont, J. W., Berg, J. S., Berkman, B. E., Bombard, Y., Holm, I. A., et al. (2015). Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Journal of Human Genetics, 97(1), 6–21.CrossRefPubMedPubMedCentral
Boycott, K., Hartley, T., Adam, S., Bernier, F., Chong, K., Fernandez, B. A., et al. (2015). The clinical application of genome-wide sequencing for monogenic diseases in Canada: position statement of the Canadian College of Medical Geneticists. Journal of Medical Genetics, 52(7), 431–437.CrossRefPubMedPubMedCentral
Bratt, E. L., Ostman-Smith, I., Sparud-Lundin, C., & Axelsson, B. A. (2011). Parents’ experiences of having an asymptomatic child diagnosed with hypertrophic cardiomyopathy through family screening. Cardiology in the Young, 21(1), 8–14.CrossRefPubMed
Bratt, E. L., Sparud-Lundin, C., Ostman-Smith, I., & Axelsson, A. B. (2012). The experience of being diagnosed with hypertrophic cardiomyopathy through family screening in childhood and adolescence. Cardiology in the Young, 22(5), 528–535.CrossRefPubMed
Charron, P., Arad, M., Arbustini, E., Basso, C., Bilinska, Z., Elliott, P., et al. (2010). Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology working group on myocardial and pericardial diseases. European Heart Journal, 31(22), 2715–2726.CrossRefPubMed
Christian, S., Somerville, M., Taylor, S., & Atallah, J. (2016). Exercise and beta-blocker therapy recommendations for inherited arrhythmogenic conditions. Cardiology in the Young, 26(6), 1123–1129.CrossRefPubMed
Corrado, D., Wichter, T., Link, M. S., Hauer, R., Marchlinski, F., Anastasakis, A., et al. (2015). Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement. European Heart Journal, 36(46), 3227–3237.PubMedPubMedCentral
Danzon, P. M. (1990). The “crisis” in medical malpractice: a comparison of trends in the United States, Canada, the United Kingdom and Australia. Law, Medicine & Health Care, 18(1–2), 48–58.CrossRef
DiLorenzo, T. M., Bargman, E. P., Stucky-Ropp, R., Brassington, G. S., Frensch, P. A., & LaFontaine, T. (1999). Long-term effects of aerobic exercise on psychological outcomes. Preventive Medicine, 28(1), 75–85.CrossRefPubMed
Douma, K. F., Aaronson, N. K., Vasen, H., Verhoef, S., Gundy, C. M., & Bleiker, E. M. (2010). Attitudes toward genetic testing in childhood and reproductive decision-making for familial adenomatous polyposis. European Journal of Human Genetics, 18(2), 186–193.CrossRefPubMed
Dunbar, S. B., Dougherty, C. M., Sears, S. F., Carroll, D. L., Goldstein, N. E., Mark, D. B., et al. (2012). Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart Association. Circulation, 126(17), 2146–2172.CrossRefPubMed
Geelen, E., Van Hoyweghen, I., Doevendans, P. A., Marcelis, C. L., & Horstman, K. (2011). Constructing “best interests”: genetic testing of children in families with hypertrophic cardiomyopathy. American Journal of Medical Genetics, 155A(8), 1930–1938.CrossRefPubMed
Gjone, H., Diseth, T. H., Fausa, O., Novik, T. S., & Heiberg, A. (2011). Familial adenomatous polyposis: mental health, psychosocial functioning and reactions to genetic risk in adolescents. Clinical Genetics, 79(1), 35–43.CrossRefPubMed
Goldenberg, I., Moss, A. J., Peterson, D. R., McNitt, S., Zareba, W., Andrews, M. L., et al. (2008). Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation, 117(17), 2184–2191.CrossRefPubMedPubMedCentral
Gollob, M. H., Blier, L., Brugada, R., Champagne, J., Chauhan, V., Connors, S., et al. (2011). Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper. The Canadian Journal of Cardiology, 27(2), 232–245.CrossRefPubMed
Hehir-Kwa, J. Y., Claustres, M., Hastings, R. J., van Ravenswaaij-Arts, C., Christenhusz, G., Genuardi, M., et al. (2015). Towards a European consensus for reporting incidental findings during clinical NGS testing. European Journal of Human Genetics, 23(12), 1601–1606.CrossRefPubMedPubMedCentral
Hein, I. M., Troost, P. W., Lindeboom, R., Christiaans, I., Grisso, T., van Goudoever, J. B., et al. (2015). Feasibility of an assessment tool for children's competence to consent to predictive genetic testing: a pilot study. Journal of Genetic Counseling, 24(6), 971–977.CrossRefPubMedPubMedCentral
Helmrich, S. P., Ragland, D. R., Leung, R. W., & Paffenbarger Jr., R. S. (1991). Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. The New England Journal of Medicine, 325(3), 147–152.CrossRefPubMed
Hershberger, R. E., Givertz, M., Ho, C. Y., Judge, D. P., Kantor, P., McBride, K. L., et al. (2018). Genetic evaluation of cardiomyopathy—a Heart Failure Society of America practice guideline. Journal of Cardiac Failure.
Ingles, J., Zodgekar, P. R., Yeates, L., Macciocca, I., Semsarian, C., & Fatkins, D. (2011). Guidelines for genetic testing of inherited cardiac disorders. Heart, Lung & Circulation, 20(11), 681–687.CrossRef
Iyer, V. R., & Chin, A. J. (2013). Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D). American Journal of Medical Genetics. Part A, 163C(3), 185–197.CrossRef
James, C. A., Bhonsale, A., Tichnell, C., Murray, B., Russell, S. D., Tandri, H., et al. (2013). Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. Journal of the American College of Cardiology, 62(14), 1290–1297.CrossRefPubMed
Kalia, S. S., Adelman, K., Bale, S. J., Chung, W. K., Eng, C., Evans, J. P., et al. (2017). Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genetics in Medicine, 19(2), 249–255.CrossRefPubMed
Kirchhof, P., Fabritz, L., Zwiener, M., Witt, H., Schafers, M., Zellerhoff, S., et al. (2006). Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation, 114(17), 1799–1806.CrossRefPubMed
Koponen, M., Marjamaa, A., Hiippala, A., Happonen, J. M., Havulinna, A. S., Salomaa, V., et al. (2015). Follow-up of 316 molecularly defined pediatric long-QT syndrome patients: Clinical course, treatments, and side effects. Circulation. Arrhythmia and Electrophysiology, 8(4), 815–823.CrossRefPubMed
Mammen, G., & Faulkner, G. (2013). Physical activity and the prevention of depression: a systematic review of prospective studies. American Journal of Preventive Medicine, 45(5), 649–657.CrossRefPubMed
Maron, B. J., Chaitman, B. R., Ackerman, M. J., Bayes de Luna, A., Corrado, D., Crosson, J. E., et al. (2004). Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation, 109(22), 2807–2816.CrossRefPubMed
Maron, B. J., Ackerman, M. J., Nishimura, R. A., Pyeritz, R. E., Towbin, J. A., & Udelson, J. E. (2005). Task force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and marfan syndrome. Journal of the American College of Cardiology, 45(8), 1340–1345.CrossRefPubMed
Maron, B. J., Udelson, J. E., Bonow, R. O., Nishimura, R. A., Ackerman, M. J., Estes 3rd, N. A., et al. (2015). Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. Circulation, 132(22), e273–e280.CrossRefPubMed
Meulenkamp, T. M., Tibben, A., Mollema, E. D., van Langen, I. M., Wiegman, A., de Wert, G. M., et al. (2008). Predictive genetic testing for cardiovascular diseases: impact on carrier children. American Journal of Medical Genetics. Part A, 146A(24), 3136–3146.CrossRefPubMed
Michie, S., Bobrow, M., & Marteau, T. M. (2001). Predictive genetic testing in children and adults: a study of emotional impact. Journal of Medical Genetics, 38(8), 519–526.CrossRefPubMedPubMedCentral
Mohammed, S., Lim, Z., Dean, P., Potts, J. E., Tang, J. N., Etheridge, S. P., et al. (2017). Genetic insurance discrimination in sudden arrhythmia death syndromes: empirical evidence from a cross-sectional survey in North America. Circulation. Cardiovascular Genetics, 10(1), e001442.CrossRefPubMed
Monico, E. P., Calise, A., & Calabro, J. (2008). Torts to contract? Moving from informed consent to shared decision-making. Journal of Healthcare Risk Management, 28(4), 7–9.CrossRefPubMed
Nocon, M., Hiemann, T., Muller-Riemenschneider, F., Thalau, F., Roll, S., & Willich, S. N. (2008). Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. European Journal of Cardiovascular Prevention and Rehabilitation, 15(3), 239–246.CrossRefPubMed
Pelliccia, A., Fagard, R., Bjornstad, H. H., Anastassakis, A., Arbustini, E., Assanelli, D., et al. (2005). Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the study group of sports cardiology of the working group of cardiac rehabilitation and exercise physiology and the working group of myocardial and pericardial diseases of the European Society of Cardiology. European Heart Journal, 26(14), 1422–1445.CrossRefPubMed
Postma, A. V., Denjoy, I., Kamblock, J., Alders, M., Lupoglazoff, J. M., Vaksmann, G., et al. (2005). Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. Journal of Medical Genetics, 42(11), 863–870.CrossRefPubMedPubMedCentral
Saberniak, J., Hasselberg, N. E., Borgquist, R., Platonov, P. G., Sarvari, S. I., Smith, H. J., et al. (2014). Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members. European Journal of Heart Failure, 16(12), 1337–1344.CrossRefPubMedPubMedCentral
Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., et al. (2014). 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). European Heart Journal, 35(39), 2733–2779.CrossRef
Villain, E., Denjoy, I., Lupoglazoff, J. M., Guicheney, P., Hainque, B., Lucet, V., et al. (2004). Low incidence of cardiac events with beta-blocking therapy in children with long QT syndrome. European Heart Journal, 25(16), 1405–1411.CrossRefPubMed
Wade, C. H., Wilfond, B. S., & McBride, C. M. (2010). Effects of genetic risk information on children’s psychosocial wellbeing: a systematic review of the literature. Genetics Medicine, 12(6), 317–326.CrossRef
Wakefield, C. E., Hanlon, L. V., Tucker, K. M., Patenaude, A. F., Signorelli, C., McLoone, J. K., et al. (2016). The psychological impact of genetic information on children: a systematic review. Genetics Medicine, 18(8), 755–762.CrossRef
Wynn, J., Martinez, J., Bulafka, J., Duong, J., Zhang, Y., Chiuzan, C., et al. (2018). Impact of receiving secondary results from genomic research: a 12-month longitudinal study. Journal of Genetic Counseling, 27(3), 709–722.CrossRefPubMed
Metadata
Title
Practice Variation among an International Group of Genetic Counselors on when to Offer Predictive Genetic Testing to Children at Risk of an Inherited Arrhythmia or Cardiomyopathy
Authors
S. Christian
M. Somerville
C. Huculak
J. Atallah
Publication date
21-08-2018
Publisher
Springer US
Published in
Journal of Genetic Counseling
Print ISSN: 1059-7700
Electronic ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-018-0293-x